Currently, there are 158.56M common shares owned by the public and among those 116.11M shares have been available to trade.
The company’s stock has a 5-day price change of 8.27% and 175.50% over the past three months. It has a 12-month low price of $36.22 and touched a high of $136.39 over the same period. ALAB has an average intraday trading volume of 4.77 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 13.19%, 40.96%, and 90.63% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Astera Labs Inc (NASDAQ: ALAB) shares accounts for 46.16% of the company’s 158.56M shares outstanding.
It has a market capitalization of $20.29B. The earnings-per-share (ttm) stands at -$0.60. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.33% over the week and 6.43% over the month.
Earnings per share for the fiscal year are expected to increase by 700.71%, and 62.07% over the next financial year.
Looking at the support for the ALAB, a number of firms have released research notes about the stock. Citigroup stated their Buy rating for the stock in a research note on November 18, 2024, with the firm’s price target at $120. Morgan Stanley coverage for the Astera Labs Inc (ALAB) stock in a research note released on September 04, 2024 offered a Overweight rating with a price target of $55. Evercore ISI was of a view on April 16, 2024 that the stock is Outperform, while Stifel gave the stock Buy rating on April 15, 2024, issuing a price target of $81. ROTH MKM on their part issued Buy rating on April 15, 2024.
